Firebrick Pharma Limited has released a press release.
Firebrick receives $293,000 R&D Tax Incentive
Earlier from Firebrick Pharma
- Appendix 4E and Annual Report 30 June 2026
- Investor Update
- March 2026 Quarterly Activity Report & Appendix 4C
- Firebrick Secures $1.5 million via Placement